APPLICATION OF DRUG CARRIERS FOR DELIVERY OF ANTINEOPLASTIC DRUGS

DOI: https://doi.org/None

A.V. Zaborovskiy, N.A. Pyataev, L.A. Tararina, K.G. Gurevich, I.V. Maev, I.S. Кrysanov, D.V. Yunina

At present, various antineoplastic agents are widely used to treat cancer. There are certain problems associated with their use, such as the inhibition of the pool of dividing cells, poor tolerance and efficiency. Targeted therapy also has several disadvantages. At first it can be used only for a small number of tumors. In addition, its use is commonly limited by the high cost.Therefore, new anticancer drugs are currently under development, but with taking into account this as a lengthy and expensive process, we should pay attention to the possibility of more efficient use of existing drugs. The possibility of targeted drug delivery with the use of various kinds of carriers is widely discussed. Currently, there is a number of drugs used for the targeted transport. Most of them are prepared at the preclinical stage of development. Nano surfaces drugs are of particular interest in view of all mentioned above. In this review the latest data on the different types of carriers for targeted delivery of the currently available chemotherapeutic drugs, as well as features of pharmacokinetics of these drugs are presented.
Keywords: 
chemotherapy, nanocarriers, directed transport

Список литературы: 
  1. Vel`sher L.Z., Kosmynin A.A., Byahov M.Yu., Dudickaya T.K., Reshetov D.N. Targetnaya terapiya – novyy podhod v lechenii mestno-rasprostranennogo raka orofaringeal`noy zony. Acta Naturae (russkoyazychnaya versiya). 2012; 4, 1 (12): 84–7. [Vel’sher L.Z., Kosmynin A.A., Bjahov M.Ju., Dudickaja T.K., Reshetov D.N. Targeted therapy – a new approach in the treatment of locally advanced oropharyngeal cancer. Acta Naturae. 2012; 4, 1 (12): 84–7 (in Russian)]
  2. Baryshnikov A.Yu. Nanostrukturirovannye liposomal`nye sistemy kak sredstvo dostavki protivoopuholevyh preparatov. Aktual`nye voprosy onkologii. Vestnik RAMN. 2012; 3. [Baryshnikov A.Ju. Nanostructured liposomal system as a means of delivery of anticancer drugs. Aktual’nye voprosy onkologii. Vestnik Rossiiskoi Akademii Meditsinskikh Nauk. 2012; 3 (in Russian)]
  3. Gorbik P.P., Petranovskaya A.L, Turelik M.P., Abramov N.P, Turanskaya S.P., Pilipchuk E.V., Chehun V.F., Luk`yanova N.Yu., Shpak A.P., Korduban A.M. Problema napravlennogo transporta lekarstvennyh preparatov: sostoyanie i perspektivy. Himiya, fizika i tehnologiya poverhnostey. 2011; 2 (4): 461–9. [Gorbik P.P., Petranovskaja A.L, Turelik M.P., Abramov N.P, Turanskaja S.P., Pilipchuk E.V., Chehun V.F., Luk’janova N.Ju., Shpak A.P., Korduban A.M. The problem of drugs targeted transport: state and prospects. Himija, fizika i tehnologija poverhnostej. 2011; 2 (4): 461–9 (in Russian)]
  4. Ivonin A.G., Pimenov E.V., Oborin V.A., Devrishov D.A., Kopylov S.N. Napravlennyy transport lekarstvennyh preparatov: sovremennoe sostoyanie voprosa i perspektivy. Izvestiya Komi nauchnogo centra Uro RAN. Vypusk 1 (9). Syktyvkar, 2012; 46–53. [Ivonin A.G., Pimenov E.V., Oborin V.A., Devrishov D.A., Kopylov S.N. Directed transport drugs: state of the art and perspectives. Izvestija Komi nauchnogo centra Uro RAN. Vypusk 1 (9). Syktyvkar, 2012; 46–53 (in Russian)]
  5. Provotorov V.M., Ivanova G.A. Rol` i mesto e`ritrocitov v sisteme napravlennogo transporta razlichnyh farmakologicheskih sredstv. Klinicheskaya medicina. 2009; 9: 4–8. [Provotorov V.M., Ivanova G.A. The role and place of red blood cells in the system of directional transport of various pharmacological agents. Klinicheskaja medicina. 2009; 9: 4–8 (in Russian)]
  6. Yabbarov N.G., Posypanova G.A., Voroncov E.A., Popova O.N., Severin E.S. Napravlennyy transport doksorubicina: sistema dostavki na osnove RAMAM dendrimerov. Biohimiya. 2013; 78 (8): 1128–40. [Jabbarov N.G., Posypanova G.A., Voroncov E.A., Popova O.N., Severin E.S. Directed transport doxorubicin: a delivery system based on RAMAM dendrimers. Biochemistry (Moscow). 2013; 78 (8): 1128–40 (in Russian)]
  7. Chao Liang, Ligeng Xu, Guosheng Song and Zhuang Liu. Emerging nanomedicine approaches fighting tumor metastasis: animal models, metastasis-targeted drug delivery, phototerapy, andimmunoterapy. J. Chem Soc Rev. 2016.
  8. Zyrnyaeva N.N., Minaeva O.V., Brodovskaya E.P., Stolyarov G.S., Firstov S.A., Zaborovskiy A.V., Shemsutdinova E.E`. Sravnitel`naya e`ffektivnost` nekotoryh metodov targetnoy himioterapii pri e`ksperimental`noy karcinome RS-1 u krys. Sovremennye problemy nauki i obrazovaniya. 2015; 6–0: 76. [Zyrnjaeva N.N., Minaeva O.V., Brodovskaja E.P., Stoljarov G.S., Firstov S.A., Zaborovskij A.V., Shemsutdinova E.Je. Comparative effectiveness of some methods of targeted chemotherapy with the experimental carcinoma PC-1 in rats. Sovremennye problemy nauki i obrazovanija. 2015; 6–0: 76 (in Russian)]
  9. Gel`perina S.E`., Smirnova Z.S., Skidan I.N., Kroyter Y. Issledovanie nanosomal`noy lekarstvennoy formy doksorubicina. Rossiyskiy bioterapevticheskiy zhurnal. 2004; 3 (3): 56–64. [Gel’perina S.Je., Smirnova Z.S., Skidan I.N., Krojter J. Research nanoparticle formulation of doxorubicin. Rossijskij bioterapevticheskij zhurnal. 2004; 3 (3): 56–64 (in Russian)]
  10. Pyataev N.A., Minaeva O.V., Zyrnyaeva N.N., Kokorev A.V., Gurevich K.G., Zaborovskiy A.V., Shhukin S.A. E`ffektivnost` DNK-kon``yugirovannyh form doksirubicina i cisplatina pri holangiocellyulyarnoy karcinome u krys. Fundamental`nye issledovaniya. 2014; 10–5: 959–63. [Pjataev N.A., Minaeva O.V., Zyrnjaeva N.N., Kokorev A.V., Gurevich K.G., Zabo-rovskij A.V., Shhukin S.A. Efficiency of DNA-conjugated forms doxirubicin and cholangiocellular carcinoma with cisplatin in the rat. Fundamental’nye issledovanija. 2014; 10–5: 959–63 (in Russian)]
  11. Starostin K.M., Olenin A.Yu., Fedotcheva T.A., Shirokih K.E., Lisichkin G.V., Shimanovskiy N.L. Poluchenie i antiproliferativnye svoystva kon``yugatov doksirubicina s biosovmestimymi superparamagnitnymi nanochasticami oksida zheleza. Vestnik Rossiyskogo gosudarstvennogo medicinskogo universiteta. 2015; 4: 58–64. [Starostin K.M., Olenin A.Ju., Fedotcheva T.A., Shirokih K.E., Lisichkin G.V., Shimanovskij N.L. Preparation and anti-proliferative properties of doxirubicin conjugates with biocompatible superparamagnetic iron oxide nanoparticles. Vestnik Rossijskogo gosudarstvennogo medicinskogo universiteta. 2015; 4: 58–64 (in Russian)]
  12. Sanzhakov M.A., Ignatov D.V., Kostryukova L.V., Druzhilovskaya O.S., Medvedeva N.V., Prozorovskiy V.N., Ipatova O.M. Izuchenie svoystv lekarstvennyh kompoziciy doksorubicina v sostave kolloidnyh nanochastic s adresnym fragmentom v e`ksperimentah in vivo. Biomedicinskaya himiya. 2016; 62 (2): 150–3. [Sanzhakov M.A., Ignatov D.V., Kostrjukova L.V., Druzhilovskaja O.S., Medve-deva N.V., Prozorovskij V.N., Ipatova O.M. Studying the properties of drug formulations of doxorubicin as part of the number-halide nanoparticles with a targeted moiety in vivo experiments. Biomedicinskaja himija. 2016; 62 (2): 150–3 (in Russian)]
  13. Moskaleva E.Yu., Semochkina Yu.P., Rodina A.V., Severin S.E. Analogi somatostatina v kachestve vektornyh molekul dlya sozdaniya targetnyh protivoopuholevyh preparatov. Molekulyarnaya medicina. 2014; 1: 3–12. [Moskaleva E.Ju., Semochkina Ju.P., Rodina A.V., Severin S.E. Somatostatin analogues as vector molecules to create a targeted anticancer drugs. Molmed (Russia). 2014; 1: 3–12 (in Russian)]
  14. Meshheryakov A.A. Novye vozmozhnosti himioterapii metastaticheskogo raka molochnoy zhelezy. Vestnik Moskovskogo onkologicheskogo obshhestva. 2005; 4: 4–5. [Meshherjakov A.A. New features of chemotherapy for metastatic breast cancer. Vestnik Moskovskogo onkologicheskogo obshhestva. 2005; 4: 4–5 (in Russian)]
  15. Stenina M.B. Rak yaichnikov. Sovremennye vozmozhnosti lekarstvennoy terapii. Vestnik Moskovskogo onkologicheskogo obshhestva. 2005; 4: 5–8. [Stenina M.B. Rak jaichnikov. Modern possibilities of drug therapy. Vestnik Moskovskogo onkologicheskogo obshhestva. 2005; 4: 5–8 (in Russian)]
  16. Rukavicyn O.A., Pop V.P. Sovremennye vozmozhnosti primeneniya pegelirovannogo liposomal`nogo doksirubicina (Keliks) v onkogematologii. Onkogematologiya. 2008; 1–2: 75–84. [Rukavicyn O.A., Pop V.P. Modern possibilities of the use of liposomal pegelirovannogo doxirubicin (Keliks) in oncohematology. Onkogematologija. 2008; 1–2: 75–84 (in Russian)]
  17. Rassohin V.V. VICh-infekciya i sarkoma Kaposhi. VICh-infekciya i immunosupressii. 2012; 4 (4): 7–18. [Rassohin V.V. HIV and Kaposi’s sarcoma. VICh-infekcija i immuno-supressii. 2012; 4 (4): 7–18 (in Russian)]
  18. Alphandéry E., Grand-Dewyse P. Lefèvre R.,Mandawala C.,Durand-Dubief M. Cancer therapy using nanoformulated substances: scientific, regulatory and financial aspects. Expert Rev Anticancer Theraphy. 2015; 15 (10): 1233–55.
  19. Esentaeva S.E., Chichua N.A., Musahanova Zh.S., Tumanova A.K., Makysheva A.T. Neposredstvennaya e`ffektivnost` ezhenedel`nogo rezhima «Paklitaksel+Keliks» vo vtoroy linii himioterapii disseminirovannogo raka molochnoy zhelezy. Sibirskiy onkologicheskiy zhurnal. 2011; S1: 46–7. [Esentaeva S.E., Chichua N.A., Musahanova Zh.S., Tumanova A.K., Makysheva A.T. The immediate effectiveness of weekly mode «Paclitaxel + Keliks» second-line chemotherapy metastatic breast cancer. Sibirskij onkologicheskij zhurnal. 2011; S1: 46–7 (in Russian)]
  20. Patent RF №016540 V1 Farmacevticheskaya kompoziciya dlya lecheniya tuberkuleza, sposob ee polucheniya i sposob lecheniya tuberkuleza/ Babiy V.E., Ignat`ev A.V, Gel`perina S.E`., Maksimenko O.O., Shipulo E.V., Vanchugova L.V./ OOO «Nauchno- proizvodstvennyy kompleks «Nanosistema»/ g. Moskva, Kolomenskiy proezd, dom 13a NPK «Nanosistema» - Zayavka № 2008000140; zayavl. 2008.12.30, opubl.2009. [Patent RF №016540 V1 A pharmaceutical composition for the treatment of tuberculosis, its method of preparation and method of treatment of tuberculosis / Babij V.E., Ignat’ev A.V, Gel’perina S.Je., Maksimenko O.O., Shipulo E.V., Vanchugova L.V./ OOO «Nauchno- proizvodstvennyj kompleks «Nanosistema»/ g. Moskva, Kolomenskij proezd, dom 13a NPK «Nanosistema» - Zajavka № 2008000140; zajavl. 2008.12.30, opubl.2009(in Russian)]
  21. Veevnik D.P. Problemy i perspektivy intraoperacionnoy himioterapii zlokachestvennyh opuholey golovnogo mozga. Vescі Nacyyanal`nay akade`mіі navuk Belarusі. Seryya medycynskіh navuk. 2014; 3: 113–23. [Veevnik D.P. Problems and prospects of intraoperative chemotherapy for malignant brain tumors. Proceedings of the National Academy of Sciences of Belarus. Series of Medical Sciences. 2014; 3: 113–23 (in Russian)]
  22. Balaban`yan V.Yu., Gel`perina S.E`. Osnovnye mehanizmy dostavki lekarstvennyh veshhestv v mozg s pomoshh`yu polimernyh nanochastic. Farmakokinetika i farmakodinamika. 2012; 2: 3–9. [Balaban’jan V.Ju., Gel’perina S.Je. The basic mechanisms for delivering drugs to the brain using polymeric nanoparticles. Farmakokinetika i farmakodinamika. 2012; 2: 3–9 (in Russian)]
  23. Galanov A.I., Yurmazova T.A., Savel`ev G.G., Buldakov M.A., Rudyk Yu.V., Litvyakov N.V., Nechaev K.A., Tuzikov S.A., Cherdynceva N.V., Yavorovskiy N.A. Razrabotka magnitoupravlyaemoy sistemy dlya dostavki himiopreparatov na osnove nanomkrnyh chastic zheleza. Sibirskiy onkologicheskiy zhurnal. 2008; 3: 50–7. [Galanov A.I., Jurmazova T.A., Savel’ev G.G., Buldakov M.A., Rudyk Ju.V., Litvjakov N.V., Nechaev K.A., Tuzikov S.A., Cherdynceva N.V., Javorovskij N.A. Development of magnetically controlled system to deliver chemotherapy drugs based on nanomkrnyh iron particles. Sibirskij onkologicheskij zhurnal. 2008; 3: 50–7 (in Russian)]
  24. Yurmazova T.A., Galanov A.I., Savel`ev G.G., Yavorovskiy N.A., Lobanova G.L., Mit`kina V.A. Magnitnyy nositel` dlya doksorubicina i ego himicheskaya transformaciya v model`nyh biologicheskih zhidkostyah. Izvestiya Tomskogo politehnicheskogo universiteta. Inzhiniring georesursov. 2009; 314 (3): 50–4. [Jurmazova T.A., Galanov A.I., Savel’ev G.G., Javorovskij N.A., Lobanova G.L., Mit’kina V.A. Magnetic carrier for the doxorubicin and its chemical transformation in the model of biological fluids. Izvestija Tomskogo politehnicheskogo universiteta. Inzhiniring georesursov. 2009; 314 (3): 50–4 (in Russian)]
  25. Gurevich K.G., Pyataev N.A., Belyaev A.I., Romanov M.D. Sravnitel`naya farmakokinetika e`ritromicina pri napravlennom kletochno-associirovannom transporte i vnutrivennom vvedenii u pacientov s pnevmoniey. Antibiotiki i himioterapiya. 2006; 51 (9–10): 13–7. [Gurevich K.G., Pjataev N.A., Beljaev A.I., Romanov M.D. Comparative pharmacokinetics of erythromycin in the directed transport of cell-associated and intravenous administration in patients with pneumonia Antibiotiki i Khimioterapiya. 2006; 51 (9–10): 13–7 (in Russian)]
  26. Pyataev N.A., Gurevich K.G., Belyaev A.N., Minaeva O.V. Farmakokinetika i farmakodinamika antibakterial`nyh preparatov pri napravlennom transporte u pacientov s tyazheloy pnevmoniey. Medicina kriticheskih sostoyaniy. 2008; 3 (3): 11–7. [Pjataev N.A., Gurevich K.G., Beljaev A.N., Minaeva O.V. Pharmacokinetics and pharmacodynamics of antimicrobials in the directed transport in patients with severe pneumonia. Medicina kriticheskih sostojanij. 2008; 3 (3): 11–7 (in Russian)]